Easing Your Transformation to a Digital Workflow

Title: Easing Your Transformation to a Digital Workflow
Date: Wednesday, September 17, 2025
Time: 1 p.m. ET
Presenter: Catarina Eloy, MD, PhD
How to Overcome Challenges and Gain Efficiency
Many factors can impact the success of laboratories who are moving toward digital-pathology-driven workflows. By understanding these factors, laboratories can better optimize their digital workflows to get the most out of their investments.
Anytime a new technology is added to a laboratory’s workflow, it can present unforeseen challenges to its processes. These challenges can range from quality-related issues to uncertainty in workflow continuity, among others. By understanding these potential barriers early, laboratories can help the digital transformation project progress smoothly.
In this webinar, the presenter will identify the potential workflow challenges of adopting digital processes and help participants learn how to overcome obstacles by focusing on the right pre-analytical and diagnostic workflow steps.
Learning Objectives
This webinar will help you:
- Recognize the pre-analytic steps that impact digital workflows
- Describe the diagnostic steps and challenges to implementing digital workflows
- Explain process improvements that can be made to optimize your digital workflow
- Discuss how the use of digital processes and AI can help you improve efficiency
Fisher Healthcare is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.™ Program. One P.A.C.E.™ credit-hour will be provided for this complimentary basic level program.
Presenter

Catarina Eloy, MD, PhD
Dr. Catarina Eloy is a pathologist and director of the Institute of Molecular Pathology and Immunology at the University of Porto (IPATIMUP). In this webinar, she’ll discuss the transformation of IPATIMUP to a fully integrated digital pathology laboratory and how new technology is helping improve diagnostic efficiency and patient treatment outcomes in Portugal.